nodes	percent_of_prediction	percent_of_DWPC	metapath
Simvastatin—UGT2B7—Epirubicin—thyroid cancer	0.151	0.195	CbGbCtD
Simvastatin—UGT1A1—Sorafenib—thyroid cancer	0.114	0.147	CbGbCtD
Simvastatin—ABCC2—Sorafenib—thyroid cancer	0.0694	0.0896	CbGbCtD
Simvastatin—CYP3A7—Sorafenib—thyroid cancer	0.0464	0.0599	CbGbCtD
Simvastatin—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0464	0.0599	CbGbCtD
Simvastatin—CYP2B6—Sorafenib—thyroid cancer	0.0442	0.057	CbGbCtD
Simvastatin—ABCC2—Doxorubicin—thyroid cancer	0.0421	0.0544	CbGbCtD
Simvastatin—CYP3A5—Sorafenib—thyroid cancer	0.0348	0.0449	CbGbCtD
Simvastatin—CYP2C8—Sorafenib—thyroid cancer	0.0334	0.0432	CbGbCtD
Simvastatin—CYP2C19—Sorafenib—thyroid cancer	0.0281	0.0362	CbGbCtD
Simvastatin—CYP2B6—Doxorubicin—thyroid cancer	0.0268	0.0346	CbGbCtD
Simvastatin—CYP2C9—Sorafenib—thyroid cancer	0.0233	0.0301	CbGbCtD
Simvastatin—ABCB1—Sorafenib—thyroid cancer	0.0226	0.0292	CbGbCtD
Simvastatin—CYP3A4—Vandetanib—thyroid cancer	0.0225	0.029	CbGbCtD
Simvastatin—CYP2D6—Sorafenib—thyroid cancer	0.0213	0.0275	CbGbCtD
Simvastatin—ABCB1—Doxorubicin—thyroid cancer	0.0137	0.0177	CbGbCtD
Simvastatin—CYP3A4—Sorafenib—thyroid cancer	0.0136	0.0175	CbGbCtD
Simvastatin—CYP2D6—Doxorubicin—thyroid cancer	0.0129	0.0167	CbGbCtD
Simvastatin—CYP3A4—Doxorubicin—thyroid cancer	0.00823	0.0106	CbGbCtD
Simvastatin—Protein urine present—Sorafenib—thyroid cancer	0.00182	0.0107	CcSEcCtD
Simvastatin—Drug interaction—Sorafenib—thyroid cancer	0.00175	0.0103	CcSEcCtD
Simvastatin—Polyneuropathy—Doxorubicin—thyroid cancer	0.0017	0.01	CcSEcCtD
Simvastatin—Gastritis—Vandetanib—thyroid cancer	0.00155	0.00912	CcSEcCtD
Simvastatin—Pancreatitis—Vandetanib—thyroid cancer	0.00148	0.00873	CcSEcCtD
Simvastatin—Gynaecomastia—Sorafenib—thyroid cancer	0.00145	0.00856	CcSEcCtD
Simvastatin—Bronchitis—Vandetanib—thyroid cancer	0.00145	0.00856	CcSEcCtD
Simvastatin—Upper respiratory tract infection—Vandetanib—thyroid cancer	0.0014	0.00827	CcSEcCtD
Simvastatin—Photosensitivity reaction—Vandetanib—thyroid cancer	0.00138	0.00813	CcSEcCtD
Simvastatin—Hepatic function abnormal—Sorafenib—thyroid cancer	0.00135	0.00795	CcSEcCtD
Simvastatin—Depression—Vandetanib—thyroid cancer	0.00134	0.00791	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.00134	0.00787	CcSEcCtD
Simvastatin—Eczema—Sorafenib—thyroid cancer	0.00131	0.00773	CcSEcCtD
Simvastatin—Hepatic failure—Sorafenib—thyroid cancer	0.00131	0.00773	CcSEcCtD
Simvastatin—Sinusitis—Vandetanib—thyroid cancer	0.00126	0.00745	CcSEcCtD
Simvastatin—Erythema multiforme—Vandetanib—thyroid cancer	0.00114	0.00674	CcSEcCtD
Simvastatin—Alopecia—Vandetanib—thyroid cancer	0.00107	0.0063	CcSEcCtD
Simvastatin—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.00106	0.00626	CcSEcCtD
Simvastatin—Mental disorder—Vandetanib—thyroid cancer	0.00106	0.00624	CcSEcCtD
Simvastatin—Gastritis—Sorafenib—thyroid cancer	0.00104	0.00615	CcSEcCtD
Simvastatin—Dysgeusia—Vandetanib—thyroid cancer	0.00103	0.00607	CcSEcCtD
Simvastatin—Muscle spasms—Vandetanib—thyroid cancer	0.00101	0.00596	CcSEcCtD
Simvastatin—Pancreatitis—Sorafenib—thyroid cancer	0.000999	0.00589	CcSEcCtD
Simvastatin—Vision blurred—Vandetanib—thyroid cancer	0.000992	0.00585	CcSEcCtD
Simvastatin—Transaminases increased—Epirubicin—thyroid cancer	0.000987	0.00581	CcSEcCtD
Simvastatin—Tremor—Vandetanib—thyroid cancer	0.000986	0.00581	CcSEcCtD
Simvastatin—Abdominal discomfort—Sorafenib—thyroid cancer	0.000977	0.00576	CcSEcCtD
Simvastatin—Erectile dysfunction—Sorafenib—thyroid cancer	0.000939	0.00553	CcSEcCtD
Simvastatin—Transaminases increased—Doxorubicin—thyroid cancer	0.000913	0.00538	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.000901	0.00531	CcSEcCtD
Simvastatin—Chest pain—Vandetanib—thyroid cancer	0.000896	0.00528	CcSEcCtD
Simvastatin—Arthralgia—Vandetanib—thyroid cancer	0.000896	0.00528	CcSEcCtD
Simvastatin—Anxiety—Vandetanib—thyroid cancer	0.000893	0.00526	CcSEcCtD
Simvastatin—Neuropathy peripheral—Sorafenib—thyroid cancer	0.000891	0.00525	CcSEcCtD
Simvastatin—Jaundice—Sorafenib—thyroid cancer	0.000886	0.00522	CcSEcCtD
Simvastatin—Oedema—Vandetanib—thyroid cancer	0.000859	0.00506	CcSEcCtD
Simvastatin—Infection—Vandetanib—thyroid cancer	0.000854	0.00503	CcSEcCtD
Simvastatin—Thrombocytopenia—Vandetanib—thyroid cancer	0.000841	0.00496	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000783	0.00461	CcSEcCtD
Simvastatin—Insomnia—Vandetanib—thyroid cancer	0.000777	0.00458	CcSEcCtD
Simvastatin—Paraesthesia—Vandetanib—thyroid cancer	0.000772	0.00455	CcSEcCtD
Simvastatin—Erythema multiforme—Sorafenib—thyroid cancer	0.000771	0.00454	CcSEcCtD
Simvastatin—Dyspnoea—Vandetanib—thyroid cancer	0.000766	0.00451	CcSEcCtD
Simvastatin—Flushing—Sorafenib—thyroid cancer	0.000757	0.00446	CcSEcCtD
Simvastatin—Dyspepsia—Vandetanib—thyroid cancer	0.000756	0.00446	CcSEcCtD
Simvastatin—Decreased appetite—Vandetanib—thyroid cancer	0.000747	0.0044	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.000742	0.00437	CcSEcCtD
Simvastatin—Fatigue—Vandetanib—thyroid cancer	0.000741	0.00436	CcSEcCtD
Simvastatin—Pain—Vandetanib—thyroid cancer	0.000735	0.00433	CcSEcCtD
Simvastatin—Constipation—Vandetanib—thyroid cancer	0.000735	0.00433	CcSEcCtD
Simvastatin—Alopecia—Sorafenib—thyroid cancer	0.000721	0.00425	CcSEcCtD
Simvastatin—Mental disorder—Sorafenib—thyroid cancer	0.000715	0.00421	CcSEcCtD
Simvastatin—Erythema—Sorafenib—thyroid cancer	0.00071	0.00418	CcSEcCtD
Simvastatin—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000703	0.00414	CcSEcCtD
Simvastatin—Dysgeusia—Sorafenib—thyroid cancer	0.000695	0.0041	CcSEcCtD
Simvastatin—Jaundice cholestatic—Epirubicin—thyroid cancer	0.000683	0.00403	CcSEcCtD
Simvastatin—Muscle spasms—Sorafenib—thyroid cancer	0.000683	0.00402	CcSEcCtD
Simvastatin—Abdominal pain—Vandetanib—thyroid cancer	0.000679	0.004	CcSEcCtD
Simvastatin—Body temperature increased—Vandetanib—thyroid cancer	0.000679	0.004	CcSEcCtD
Simvastatin—Anaemia—Sorafenib—thyroid cancer	0.000656	0.00387	CcSEcCtD
Simvastatin—Angioedema—Sorafenib—thyroid cancer	0.000649	0.00382	CcSEcCtD
Simvastatin—Leukopenia—Sorafenib—thyroid cancer	0.000636	0.00375	CcSEcCtD
Simvastatin—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.000632	0.00373	CcSEcCtD
Simvastatin—Inflammation—Epirubicin—thyroid cancer	0.000619	0.00365	CcSEcCtD
Simvastatin—Asthenia—Vandetanib—thyroid cancer	0.000616	0.00363	CcSEcCtD
Simvastatin—Pruritus—Vandetanib—thyroid cancer	0.000608	0.00358	CcSEcCtD
Simvastatin—Arthralgia—Sorafenib—thyroid cancer	0.000605	0.00356	CcSEcCtD
Simvastatin—Myalgia—Sorafenib—thyroid cancer	0.000605	0.00356	CcSEcCtD
Simvastatin—Phosphatase alkaline increased—Epirubicin—thyroid cancer	0.0006	0.00354	CcSEcCtD
Simvastatin—Hepatocellular injury—Epirubicin—thyroid cancer	0.0006	0.00354	CcSEcCtD
Simvastatin—Diarrhoea—Vandetanib—thyroid cancer	0.000588	0.00346	CcSEcCtD
Simvastatin—Anaphylactic shock—Sorafenib—thyroid cancer	0.00058	0.00341	CcSEcCtD
Simvastatin—Infection—Sorafenib—thyroid cancer	0.000576	0.00339	CcSEcCtD
Simvastatin—Inflammation—Doxorubicin—thyroid cancer	0.000573	0.00337	CcSEcCtD
Simvastatin—Dizziness—Vandetanib—thyroid cancer	0.000568	0.00335	CcSEcCtD
Simvastatin—Thrombocytopenia—Sorafenib—thyroid cancer	0.000568	0.00334	CcSEcCtD
Simvastatin—Hepatocellular injury—Doxorubicin—thyroid cancer	0.000556	0.00327	CcSEcCtD
Simvastatin—Phosphatase alkaline increased—Doxorubicin—thyroid cancer	0.000556	0.00327	CcSEcCtD
Simvastatin—Anorexia—Sorafenib—thyroid cancer	0.000552	0.00326	CcSEcCtD
Simvastatin—Vomiting—Vandetanib—thyroid cancer	0.000546	0.00322	CcSEcCtD
Simvastatin—Rash—Vandetanib—thyroid cancer	0.000542	0.00319	CcSEcCtD
Simvastatin—Dermatitis—Vandetanib—thyroid cancer	0.000541	0.00319	CcSEcCtD
Simvastatin—Headache—Vandetanib—thyroid cancer	0.000538	0.00317	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000528	0.00311	CcSEcCtD
Simvastatin—Dyspnoea—Sorafenib—thyroid cancer	0.000517	0.00304	CcSEcCtD
Simvastatin—Nausea—Vandetanib—thyroid cancer	0.00051	0.00301	CcSEcCtD
Simvastatin—Dyspepsia—Sorafenib—thyroid cancer	0.00051	0.00301	CcSEcCtD
Simvastatin—Decreased appetite—Sorafenib—thyroid cancer	0.000504	0.00297	CcSEcCtD
Simvastatin—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.000501	0.00295	CcSEcCtD
Simvastatin—Diabetes mellitus—Epirubicin—thyroid cancer	0.000501	0.00295	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.0005	0.00295	CcSEcCtD
Simvastatin—Fatigue—Sorafenib—thyroid cancer	0.0005	0.00294	CcSEcCtD
Simvastatin—Hepatic function abnormal—Epirubicin—thyroid cancer	0.000499	0.00294	CcSEcCtD
Simvastatin—Photosensitivity—Epirubicin—thyroid cancer	0.000496	0.00292	CcSEcCtD
Simvastatin—Pain—Sorafenib—thyroid cancer	0.000496	0.00292	CcSEcCtD
Simvastatin—Constipation—Sorafenib—thyroid cancer	0.000496	0.00292	CcSEcCtD
Simvastatin—Vascular purpura—Epirubicin—thyroid cancer	0.000487	0.00287	CcSEcCtD
Simvastatin—Eczema—Epirubicin—thyroid cancer	0.000485	0.00286	CcSEcCtD
Simvastatin—Hepatic failure—Epirubicin—thyroid cancer	0.000485	0.00286	CcSEcCtD
Simvastatin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000474	0.00279	CcSEcCtD
Simvastatin—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.000464	0.00273	CcSEcCtD
Simvastatin—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000464	0.00273	CcSEcCtD
Simvastatin—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.000461	0.00272	CcSEcCtD
Simvastatin—Urticaria—Sorafenib—thyroid cancer	0.00046	0.00271	CcSEcCtD
Simvastatin—Photosensitivity—Doxorubicin—thyroid cancer	0.000459	0.00271	CcSEcCtD
Simvastatin—Abdominal pain—Sorafenib—thyroid cancer	0.000458	0.0027	CcSEcCtD
Simvastatin—Body temperature increased—Sorafenib—thyroid cancer	0.000458	0.0027	CcSEcCtD
Simvastatin—Purpura—Epirubicin—thyroid cancer	0.000452	0.00266	CcSEcCtD
Simvastatin—Vascular purpura—Doxorubicin—thyroid cancer	0.000451	0.00266	CcSEcCtD
Simvastatin—Hepatic failure—Doxorubicin—thyroid cancer	0.000449	0.00264	CcSEcCtD
Simvastatin—Eczema—Doxorubicin—thyroid cancer	0.000449	0.00264	CcSEcCtD
Simvastatin—Hypersensitivity—Sorafenib—thyroid cancer	0.000427	0.00252	CcSEcCtD
Simvastatin—Purpura—Doxorubicin—thyroid cancer	0.000418	0.00247	CcSEcCtD
Simvastatin—Asthenia—Sorafenib—thyroid cancer	0.000416	0.00245	CcSEcCtD
Simvastatin—Pruritus—Sorafenib—thyroid cancer	0.00041	0.00242	CcSEcCtD
Simvastatin—Diarrhoea—Sorafenib—thyroid cancer	0.000397	0.00234	CcSEcCtD
Simvastatin—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000392	0.00231	CcSEcCtD
Simvastatin—Gastritis—Epirubicin—thyroid cancer	0.000386	0.00227	CcSEcCtD
Simvastatin—Muscular weakness—Epirubicin—thyroid cancer	0.000384	0.00226	CcSEcCtD
Simvastatin—Dizziness—Sorafenib—thyroid cancer	0.000383	0.00226	CcSEcCtD
Simvastatin—Eosinophilia—Epirubicin—thyroid cancer	0.000373	0.0022	CcSEcCtD
Simvastatin—Pancreatitis—Epirubicin—thyroid cancer	0.000369	0.00218	CcSEcCtD
Simvastatin—Vomiting—Sorafenib—thyroid cancer	0.000369	0.00217	CcSEcCtD
Simvastatin—Rash—Sorafenib—thyroid cancer	0.000365	0.00215	CcSEcCtD
Simvastatin—Dermatitis—Sorafenib—thyroid cancer	0.000365	0.00215	CcSEcCtD
Simvastatin—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000363	0.00214	CcSEcCtD
Simvastatin—Headache—Sorafenib—thyroid cancer	0.000363	0.00214	CcSEcCtD
Simvastatin—Bronchitis—Epirubicin—thyroid cancer	0.000362	0.00213	CcSEcCtD
Simvastatin—Gastritis—Doxorubicin—thyroid cancer	0.000357	0.0021	CcSEcCtD
Simvastatin—Muscular weakness—Doxorubicin—thyroid cancer	0.000356	0.0021	CcSEcCtD
Simvastatin—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00035	0.00206	CcSEcCtD
Simvastatin—Eosinophilia—Doxorubicin—thyroid cancer	0.000345	0.00203	CcSEcCtD
Simvastatin—Nausea—Sorafenib—thyroid cancer	0.000344	0.00203	CcSEcCtD
Simvastatin—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000344	0.00203	CcSEcCtD
Simvastatin—Pancreatitis—Doxorubicin—thyroid cancer	0.000342	0.00201	CcSEcCtD
Simvastatin—Bronchitis—Doxorubicin—thyroid cancer	0.000335	0.00197	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000333	0.00196	CcSEcCtD
Simvastatin—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000329	0.00194	CcSEcCtD
Simvastatin—Jaundice—Epirubicin—thyroid cancer	0.000327	0.00193	CcSEcCtD
Simvastatin—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000324	0.00191	CcSEcCtD
Simvastatin—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000318	0.00187	CcSEcCtD
Simvastatin—Sinusitis—Epirubicin—thyroid cancer	0.000315	0.00186	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000308	0.00182	CcSEcCtD
Simvastatin—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000305	0.00179	CcSEcCtD
Simvastatin—Jaundice—Doxorubicin—thyroid cancer	0.000303	0.00178	CcSEcCtD
Simvastatin—Hepatitis—Epirubicin—thyroid cancer	0.000302	0.00178	CcSEcCtD
Simvastatin—Sinusitis—Doxorubicin—thyroid cancer	0.000292	0.00172	CcSEcCtD
Simvastatin—Erythema multiforme—Epirubicin—thyroid cancer	0.000285	0.00168	CcSEcCtD
Simvastatin—Flushing—Epirubicin—thyroid cancer	0.00028	0.00165	CcSEcCtD
Simvastatin—Hepatitis—Doxorubicin—thyroid cancer	0.000279	0.00164	CcSEcCtD
Simvastatin—Chills—Epirubicin—thyroid cancer	0.000271	0.00159	CcSEcCtD
Simvastatin—Alopecia—Epirubicin—thyroid cancer	0.000266	0.00157	CcSEcCtD
Simvastatin—Mental disorder—Epirubicin—thyroid cancer	0.000264	0.00156	CcSEcCtD
Simvastatin—Erythema multiforme—Doxorubicin—thyroid cancer	0.000264	0.00155	CcSEcCtD
Simvastatin—Erythema—Epirubicin—thyroid cancer	0.000262	0.00155	CcSEcCtD
Simvastatin—Flushing—Doxorubicin—thyroid cancer	0.000259	0.00153	CcSEcCtD
Simvastatin—Flatulence—Epirubicin—thyroid cancer	0.000259	0.00152	CcSEcCtD
Simvastatin—Dysgeusia—Epirubicin—thyroid cancer	0.000257	0.00151	CcSEcCtD
Simvastatin—Muscle spasms—Epirubicin—thyroid cancer	0.000252	0.00149	CcSEcCtD
Simvastatin—Chills—Doxorubicin—thyroid cancer	0.00025	0.00147	CcSEcCtD
Simvastatin—Vision blurred—Epirubicin—thyroid cancer	0.000247	0.00146	CcSEcCtD
Simvastatin—Alopecia—Doxorubicin—thyroid cancer	0.000247	0.00145	CcSEcCtD
Simvastatin—Mental disorder—Doxorubicin—thyroid cancer	0.000244	0.00144	CcSEcCtD
Simvastatin—Ill-defined disorder—Epirubicin—thyroid cancer	0.000244	0.00143	CcSEcCtD
Simvastatin—Erythema—Doxorubicin—thyroid cancer	0.000243	0.00143	CcSEcCtD
Simvastatin—Anaemia—Epirubicin—thyroid cancer	0.000243	0.00143	CcSEcCtD
Simvastatin—Flatulence—Doxorubicin—thyroid cancer	0.000239	0.00141	CcSEcCtD
Simvastatin—Dysgeusia—Doxorubicin—thyroid cancer	0.000238	0.0014	CcSEcCtD
Simvastatin—Malaise—Epirubicin—thyroid cancer	0.000237	0.00139	CcSEcCtD
Simvastatin—Vertigo—Epirubicin—thyroid cancer	0.000236	0.00139	CcSEcCtD
Simvastatin—Leukopenia—Epirubicin—thyroid cancer	0.000235	0.00138	CcSEcCtD
Simvastatin—Muscle spasms—Doxorubicin—thyroid cancer	0.000233	0.00138	CcSEcCtD
Simvastatin—Vision blurred—Doxorubicin—thyroid cancer	0.000229	0.00135	CcSEcCtD
Simvastatin—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000225	0.00133	CcSEcCtD
Simvastatin—Anaemia—Doxorubicin—thyroid cancer	0.000224	0.00132	CcSEcCtD
Simvastatin—Arthralgia—Epirubicin—thyroid cancer	0.000223	0.00132	CcSEcCtD
Simvastatin—Chest pain—Epirubicin—thyroid cancer	0.000223	0.00132	CcSEcCtD
Simvastatin—Myalgia—Epirubicin—thyroid cancer	0.000223	0.00132	CcSEcCtD
Simvastatin—Anxiety—Epirubicin—thyroid cancer	0.000223	0.00131	CcSEcCtD
Simvastatin—Discomfort—Epirubicin—thyroid cancer	0.000221	0.0013	CcSEcCtD
Simvastatin—Malaise—Doxorubicin—thyroid cancer	0.000219	0.00129	CcSEcCtD
Simvastatin—Vertigo—Doxorubicin—thyroid cancer	0.000218	0.00129	CcSEcCtD
Simvastatin—Leukopenia—Doxorubicin—thyroid cancer	0.000217	0.00128	CcSEcCtD
Simvastatin—Confusional state—Epirubicin—thyroid cancer	0.000216	0.00127	CcSEcCtD
Simvastatin—Anaphylactic shock—Epirubicin—thyroid cancer	0.000214	0.00126	CcSEcCtD
Simvastatin—Oedema—Epirubicin—thyroid cancer	0.000214	0.00126	CcSEcCtD
Simvastatin—Infection—Epirubicin—thyroid cancer	0.000213	0.00125	CcSEcCtD
Simvastatin—Thrombocytopenia—Epirubicin—thyroid cancer	0.00021	0.00124	CcSEcCtD
Simvastatin—Arthralgia—Doxorubicin—thyroid cancer	0.000207	0.00122	CcSEcCtD
Simvastatin—Chest pain—Doxorubicin—thyroid cancer	0.000207	0.00122	CcSEcCtD
Simvastatin—Myalgia—Doxorubicin—thyroid cancer	0.000207	0.00122	CcSEcCtD
Simvastatin—Anxiety—Doxorubicin—thyroid cancer	0.000206	0.00121	CcSEcCtD
Simvastatin—Discomfort—Doxorubicin—thyroid cancer	0.000204	0.0012	CcSEcCtD
Simvastatin—Anorexia—Epirubicin—thyroid cancer	0.000204	0.0012	CcSEcCtD
Simvastatin—Confusional state—Doxorubicin—thyroid cancer	0.0002	0.00118	CcSEcCtD
Simvastatin—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000198	0.00117	CcSEcCtD
Simvastatin—Oedema—Doxorubicin—thyroid cancer	0.000198	0.00117	CcSEcCtD
Simvastatin—Infection—Doxorubicin—thyroid cancer	0.000197	0.00116	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000195	0.00115	CcSEcCtD
Simvastatin—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000194	0.00114	CcSEcCtD
Simvastatin—Insomnia—Epirubicin—thyroid cancer	0.000194	0.00114	CcSEcCtD
Simvastatin—Paraesthesia—Epirubicin—thyroid cancer	0.000192	0.00113	CcSEcCtD
Simvastatin—Dyspnoea—Epirubicin—thyroid cancer	0.000191	0.00113	CcSEcCtD
Simvastatin—Anorexia—Doxorubicin—thyroid cancer	0.000189	0.00111	CcSEcCtD
Simvastatin—Dyspepsia—Epirubicin—thyroid cancer	0.000189	0.00111	CcSEcCtD
Simvastatin—Decreased appetite—Epirubicin—thyroid cancer	0.000186	0.0011	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000185	0.00109	CcSEcCtD
Simvastatin—Fatigue—Epirubicin—thyroid cancer	0.000185	0.00109	CcSEcCtD
Simvastatin—Pain—Epirubicin—thyroid cancer	0.000183	0.00108	CcSEcCtD
Simvastatin—Constipation—Epirubicin—thyroid cancer	0.000183	0.00108	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000181	0.00106	CcSEcCtD
Simvastatin—Insomnia—Doxorubicin—thyroid cancer	0.000179	0.00106	CcSEcCtD
Simvastatin—Paraesthesia—Doxorubicin—thyroid cancer	0.000178	0.00105	CcSEcCtD
Simvastatin—Dyspnoea—Doxorubicin—thyroid cancer	0.000177	0.00104	CcSEcCtD
Simvastatin—Feeling abnormal—Epirubicin—thyroid cancer	0.000177	0.00104	CcSEcCtD
Simvastatin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000175	0.00103	CcSEcCtD
Simvastatin—Dyspepsia—Doxorubicin—thyroid cancer	0.000174	0.00103	CcSEcCtD
Simvastatin—Decreased appetite—Doxorubicin—thyroid cancer	0.000172	0.00102	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000171	0.00101	CcSEcCtD
Simvastatin—Fatigue—Doxorubicin—thyroid cancer	0.000171	0.00101	CcSEcCtD
Simvastatin—Urticaria—Epirubicin—thyroid cancer	0.00017	0.001	CcSEcCtD
Simvastatin—Pain—Doxorubicin—thyroid cancer	0.000169	0.000999	CcSEcCtD
Simvastatin—Constipation—Doxorubicin—thyroid cancer	0.000169	0.000999	CcSEcCtD
Simvastatin—Abdominal pain—Epirubicin—thyroid cancer	0.000169	0.000998	CcSEcCtD
Simvastatin—Body temperature increased—Epirubicin—thyroid cancer	0.000169	0.000998	CcSEcCtD
Simvastatin—Feeling abnormal—Doxorubicin—thyroid cancer	0.000163	0.000962	CcSEcCtD
Simvastatin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000162	0.000955	CcSEcCtD
Simvastatin—Hypersensitivity—Epirubicin—thyroid cancer	0.000158	0.00093	CcSEcCtD
Simvastatin—Urticaria—Doxorubicin—thyroid cancer	0.000157	0.000928	CcSEcCtD
Simvastatin—Abdominal pain—Doxorubicin—thyroid cancer	0.000157	0.000923	CcSEcCtD
Simvastatin—Body temperature increased—Doxorubicin—thyroid cancer	0.000157	0.000923	CcSEcCtD
Simvastatin—Asthenia—Epirubicin—thyroid cancer	0.000154	0.000906	CcSEcCtD
Simvastatin—Pruritus—Epirubicin—thyroid cancer	0.000152	0.000893	CcSEcCtD
Simvastatin—Diarrhoea—Epirubicin—thyroid cancer	0.000147	0.000864	CcSEcCtD
Simvastatin—Hypersensitivity—Doxorubicin—thyroid cancer	0.000146	0.00086	CcSEcCtD
Simvastatin—Asthenia—Doxorubicin—thyroid cancer	0.000142	0.000838	CcSEcCtD
Simvastatin—Dizziness—Epirubicin—thyroid cancer	0.000142	0.000835	CcSEcCtD
Simvastatin—Pruritus—Doxorubicin—thyroid cancer	0.00014	0.000826	CcSEcCtD
Simvastatin—Vomiting—Epirubicin—thyroid cancer	0.000136	0.000802	CcSEcCtD
Simvastatin—Diarrhoea—Doxorubicin—thyroid cancer	0.000136	0.000799	CcSEcCtD
Simvastatin—Rash—Epirubicin—thyroid cancer	0.000135	0.000796	CcSEcCtD
Simvastatin—Dermatitis—Epirubicin—thyroid cancer	0.000135	0.000795	CcSEcCtD
Simvastatin—Headache—Epirubicin—thyroid cancer	0.000134	0.000791	CcSEcCtD
Simvastatin—Dizziness—Doxorubicin—thyroid cancer	0.000131	0.000772	CcSEcCtD
Simvastatin—Nausea—Epirubicin—thyroid cancer	0.000127	0.00075	CcSEcCtD
Simvastatin—Vomiting—Doxorubicin—thyroid cancer	0.000126	0.000742	CcSEcCtD
Simvastatin—Rash—Doxorubicin—thyroid cancer	0.000125	0.000736	CcSEcCtD
Simvastatin—Dermatitis—Doxorubicin—thyroid cancer	0.000125	0.000736	CcSEcCtD
Simvastatin—Headache—Doxorubicin—thyroid cancer	0.000124	0.000732	CcSEcCtD
Simvastatin—Nausea—Doxorubicin—thyroid cancer	0.000118	0.000694	CcSEcCtD
Simvastatin—ITGB2—Hemostasis—NRAS—thyroid cancer	9.41e-05	0.0017	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—CHST14—thyroid cancer	9.37e-05	0.00169	CbGpPWpGaD
Simvastatin—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	9.34e-05	0.00168	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—NDUFA13—thyroid cancer	9.3e-05	0.00168	CbGpPWpGaD
Simvastatin—SLCO1A2—Transmembrane transport of small molecules—CP—thyroid cancer	9.26e-05	0.00167	CbGpPWpGaD
Simvastatin—SLCO1A2—Transmembrane transport of small molecules—TPR—thyroid cancer	9.26e-05	0.00167	CbGpPWpGaD
Simvastatin—CYP2B6—Biological oxidations—RXRA—thyroid cancer	9.26e-05	0.00167	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—MINPP1—thyroid cancer	9.2e-05	0.00166	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—PTEN—thyroid cancer	9.12e-05	0.00164	CbGpPWpGaD
Simvastatin—SLCO1A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	9.11e-05	0.00164	CbGpPWpGaD
Simvastatin—CYP3A5—Biological oxidations—RXRA—thyroid cancer	9.05e-05	0.00163	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—CHST14—thyroid cancer	8.74e-05	0.00158	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—HPGD—thyroid cancer	8.67e-05	0.00156	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—thyroid cancer	8.67e-05	0.00156	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—NDUFA13—thyroid cancer	8.52e-05	0.00154	CbGpPWpGaD
Simvastatin—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	8.51e-05	0.00153	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—NRAS—thyroid cancer	8.47e-05	0.00153	CbGpPWpGaD
Simvastatin—ABCC2—Transmembrane transport of small molecules—TPR—thyroid cancer	8.43e-05	0.00152	CbGpPWpGaD
Simvastatin—ABCC2—Transmembrane transport of small molecules—CP—thyroid cancer	8.43e-05	0.00152	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	8.33e-05	0.0015	CbGpPWpGaD
Simvastatin—ABCC2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.29e-05	0.00149	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—NRAS—thyroid cancer	8.14e-05	0.00147	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—KRAS—thyroid cancer	8.1e-05	0.00146	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—CHST14—thyroid cancer	8.01e-05	0.00144	CbGpPWpGaD
Simvastatin—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	7.92e-05	0.00143	CbGpPWpGaD
Simvastatin—SLCO1B1—Transmembrane transport of small molecules—TPR—thyroid cancer	7.92e-05	0.00143	CbGpPWpGaD
Simvastatin—SLCO1B1—Transmembrane transport of small molecules—CP—thyroid cancer	7.92e-05	0.00143	CbGpPWpGaD
Simvastatin—CYP2C8—Biological oxidations—RXRA—thyroid cancer	7.84e-05	0.00141	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—NDUFA13—thyroid cancer	7.82e-05	0.00141	CbGpPWpGaD
Simvastatin—SLCO1B1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	7.79e-05	0.0014	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—HPGD—thyroid cancer	7.55e-05	0.00136	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	7.44e-05	0.00134	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—CHST14—thyroid cancer	7.35e-05	0.00133	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	7.32e-05	0.00132	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—KRAS—thyroid cancer	7.29e-05	0.00131	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—TP53—thyroid cancer	7.2e-05	0.0013	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—TPR—thyroid cancer	7.19e-05	0.0013	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—PRKAR1A—thyroid cancer	7.07e-05	0.00127	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—HPGD—thyroid cancer	7.05e-05	0.00127	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—KRAS—thyroid cancer	7e-05	0.00126	CbGpPWpGaD
Simvastatin—CYP2C19—Biological oxidations—RXRA—thyroid cancer	7e-05	0.00126	CbGpPWpGaD
Simvastatin—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.93e-05	0.00125	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—HRAS—thyroid cancer	6.89e-05	0.00124	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—MINPP1—thyroid cancer	6.8e-05	0.00123	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	6.78e-05	0.00122	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—MINPP1—thyroid cancer	6.65e-05	0.0012	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—HPGD—thyroid cancer	6.46e-05	0.00116	CbGpPWpGaD
Simvastatin—CYP2D6—Biological oxidations—RXRA—thyroid cancer	6.43e-05	0.00116	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.41e-05	0.00115	CbGpPWpGaD
Simvastatin—CYP2C9—Biological oxidations—RXRA—thyroid cancer	6.38e-05	0.00115	CbGpPWpGaD
Simvastatin—ABCC2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.31e-05	0.00114	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	6.28e-05	0.00113	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—HRAS—thyroid cancer	6.2e-05	0.00112	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.13e-05	0.0011	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—AKT1—thyroid cancer	6.08e-05	0.0011	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—HRAS—thyroid cancer	5.95e-05	0.00107	CbGpPWpGaD
Simvastatin—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.93e-05	0.00107	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—HPGD—thyroid cancer	5.93e-05	0.00107	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—TPR—thyroid cancer	5.86e-05	0.00106	CbGpPWpGaD
Simvastatin—SLCO1A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.82e-05	0.00105	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—NDUFA13—thyroid cancer	5.78e-05	0.00104	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PRKAR1A—thyroid cancer	5.76e-05	0.00104	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—MINPP1—thyroid cancer	5.76e-05	0.00104	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—NDUFA13—thyroid cancer	5.65e-05	0.00102	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—PTEN—thyroid cancer	5.53e-05	0.000997	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—AKT1—thyroid cancer	5.47e-05	0.000987	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—CHST14—thyroid cancer	5.44e-05	0.00098	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—SLC5A5—thyroid cancer	5.38e-05	0.000969	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—CHST14—thyroid cancer	5.31e-05	0.000958	CbGpPWpGaD
Simvastatin—ABCC2—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.3e-05	0.000956	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—AKT1—thyroid cancer	5.26e-05	0.000947	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.24e-05	0.000944	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—MINPP1—thyroid cancer	5.14e-05	0.000926	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.04e-05	0.000908	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—MINPP1—thyroid cancer	5.02e-05	0.000904	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—TPR—thyroid cancer	4.98e-05	0.000898	CbGpPWpGaD
Simvastatin—SLCO1B1—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.98e-05	0.000898	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—NRAS—thyroid cancer	4.94e-05	0.00089	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PRKAR1A—thyroid cancer	4.9e-05	0.000883	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—NDUFA13—thyroid cancer	4.9e-05	0.000882	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—MINPP1—thyroid cancer	4.73e-05	0.000852	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—MINPP1—thyroid cancer	4.69e-05	0.000845	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—CHST14—thyroid cancer	4.6e-05	0.00083	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—RXRA—thyroid cancer	4.52e-05	0.000815	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.4e-05	0.000792	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—SLC5A5—thyroid cancer	4.38e-05	0.00079	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—HPGD—thyroid cancer	4.38e-05	0.00079	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—NDUFA13—thyroid cancer	4.37e-05	0.000788	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—TPR—thyroid cancer	4.34e-05	0.000782	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—HPGD—thyroid cancer	4.28e-05	0.000772	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PRKAR1A—thyroid cancer	4.27e-05	0.000769	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—NDUFA13—thyroid cancer	4.27e-05	0.000769	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—KRAS—thyroid cancer	4.25e-05	0.000766	CbGpPWpGaD
Simvastatin—CYP3A4—Biological oxidations—RXRA—thyroid cancer	4.21e-05	0.000758	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CHST14—thyroid cancer	4.11e-05	0.000741	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—TPR—thyroid cancer	4.05e-05	0.000729	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—NDUFA13—thyroid cancer	4.02e-05	0.000724	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CHST14—thyroid cancer	4.01e-05	0.000723	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—NDUFA13—thyroid cancer	3.98e-05	0.000718	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PRKAR1A—thyroid cancer	3.98e-05	0.000718	CbGpPWpGaD
Simvastatin—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	3.96e-05	0.000714	CbGpPWpGaD
Simvastatin—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	3.96e-05	0.000714	CbGpPWpGaD
Simvastatin—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.9e-05	0.000703	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.87e-05	0.000697	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CHST14—thyroid cancer	3.78e-05	0.000681	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CHST14—thyroid cancer	3.75e-05	0.000675	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—SLC5A5—thyroid cancer	3.73e-05	0.000672	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—HPGD—thyroid cancer	3.71e-05	0.000669	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—TPR—thyroid cancer	3.71e-05	0.000668	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—RXRA—thyroid cancer	3.68e-05	0.000664	CbGpPWpGaD
Simvastatin—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	3.67e-05	0.000661	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PRKAR1A—thyroid cancer	3.65e-05	0.000658	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—HRAS—thyroid cancer	3.61e-05	0.000651	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—TPR—thyroid cancer	3.4e-05	0.000613	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	3.35e-05	0.000604	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—HPGD—thyroid cancer	3.31e-05	0.000597	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.31e-05	0.000596	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—SLC5A5—thyroid cancer	3.25e-05	0.000585	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—HPGD—thyroid cancer	3.23e-05	0.000583	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—AKT1—thyroid cancer	3.19e-05	0.000575	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—RXRA—thyroid cancer	3.13e-05	0.000565	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	3.12e-05	0.000562	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—MINPP1—thyroid cancer	3.09e-05	0.000557	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—HPGD—thyroid cancer	3.05e-05	0.000549	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.04e-05	0.000548	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—SLC5A5—thyroid cancer	3.03e-05	0.000546	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—HPGD—thyroid cancer	3.02e-05	0.000544	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.01e-05	0.000542	CbGpPWpGaD
Simvastatin—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.97e-05	0.000535	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—PPARG—thyroid cancer	2.85e-05	0.000514	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	2.82e-05	0.000508	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—SLC5A5—thyroid cancer	2.78e-05	0.0005	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—RXRA—thyroid cancer	2.73e-05	0.000492	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	2.72e-05	0.00049	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.69e-05	0.000484	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.65e-05	0.000478	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—NDUFA13—thyroid cancer	2.63e-05	0.000474	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.6e-05	0.000469	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—SLC5A5—thyroid cancer	2.55e-05	0.000459	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—RXRA—thyroid cancer	2.55e-05	0.000459	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—TPR—thyroid cancer	2.52e-05	0.000454	CbGpPWpGaD
Simvastatin—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.49e-05	0.000449	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	2.48e-05	0.000446	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CHST14—thyroid cancer	2.47e-05	0.000445	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—TPR—thyroid cancer	2.46e-05	0.000443	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.45e-05	0.000441	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	2.42e-05	0.000436	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—RXRA—thyroid cancer	2.33e-05	0.00042	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PPARG—thyroid cancer	2.33e-05	0.000419	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.27e-05	0.000409	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—PTGS2—thyroid cancer	2.24e-05	0.000405	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—RXRA—thyroid cancer	2.14e-05	0.000386	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—TPR—thyroid cancer	2.13e-05	0.000384	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	2.1e-05	0.000378	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	2.09e-05	0.000376	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—HPGD—thyroid cancer	1.99e-05	0.000359	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PPARG—thyroid cancer	1.98e-05	0.000356	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—PTEN—thyroid cancer	1.96e-05	0.000353	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—TPR—thyroid cancer	1.9e-05	0.000343	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.9e-05	0.000343	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—SLC5A5—thyroid cancer	1.88e-05	0.00034	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	1.87e-05	0.000337	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—TPR—thyroid cancer	1.86e-05	0.000335	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.86e-05	0.000335	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—SLC5A5—thyroid cancer	1.84e-05	0.000332	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PTGS2—thyroid cancer	1.83e-05	0.00033	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PRKAR1A—thyroid cancer	1.83e-05	0.000329	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—TPR—thyroid cancer	1.75e-05	0.000315	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—TPR—thyroid cancer	1.73e-05	0.000313	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PPARG—thyroid cancer	1.72e-05	0.00031	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.72e-05	0.00031	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.71e-05	0.000308	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.7e-05	0.000306	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PPARG—thyroid cancer	1.61e-05	0.00029	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PTEN—thyroid cancer	1.6e-05	0.000288	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—SLC5A5—thyroid cancer	1.6e-05	0.000288	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—RXRA—thyroid cancer	1.58e-05	0.000285	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.57e-05	0.000283	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PTGS2—thyroid cancer	1.56e-05	0.00028	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—RXRA—thyroid cancer	1.55e-05	0.000279	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.55e-05	0.000279	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.49e-05	0.000269	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PPARG—thyroid cancer	1.47e-05	0.000265	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—SLC5A5—thyroid cancer	1.42e-05	0.000257	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.39e-05	0.000251	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PTEN—thyroid cancer	1.36e-05	0.000245	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PTGS2—thyroid cancer	1.35e-05	0.000244	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PPARG—thyroid cancer	1.35e-05	0.000244	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—RXRA—thyroid cancer	1.34e-05	0.000242	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.33e-05	0.00024	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.31e-05	0.000236	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.3e-05	0.000235	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.3e-05	0.000234	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PTGS2—thyroid cancer	1.26e-05	0.000228	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.22e-05	0.000219	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—RXRA—thyroid cancer	1.2e-05	0.000216	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PTEN—thyroid cancer	1.18e-05	0.000213	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—RXRA—thyroid cancer	1.17e-05	0.00021	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.16e-05	0.00021	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PTGS2—thyroid cancer	1.16e-05	0.000209	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—TPR—thyroid cancer	1.14e-05	0.000206	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—AKT1—thyroid cancer	1.13e-05	0.000203	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.13e-05	0.000203	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PTEN—thyroid cancer	1.1e-05	0.000199	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—RXRA—thyroid cancer	1.1e-05	0.000198	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—RXRA—thyroid cancer	1.09e-05	0.000197	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PTGS2—thyroid cancer	1.06e-05	0.000192	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.06e-05	0.000191	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PTEN—thyroid cancer	1.01e-05	0.000182	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PPARG—thyroid cancer	1e-05	0.00018	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PPARG—thyroid cancer	9.77e-06	0.000176	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PTEN—thyroid cancer	9.27e-06	0.000167	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—AKT1—thyroid cancer	9.2e-06	0.000166	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—SLC5A5—thyroid cancer	8.56e-06	0.000154	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PPARG—thyroid cancer	8.46e-06	0.000153	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PTGS2—thyroid cancer	7.86e-06	0.000142	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—AKT1—thyroid cancer	7.82e-06	0.000141	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PTGS2—thyroid cancer	7.69e-06	0.000139	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PPARG—thyroid cancer	7.55e-06	0.000136	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PPARG—thyroid cancer	7.37e-06	0.000133	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—RXRA—thyroid cancer	7.19e-06	0.00013	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PPARG—thyroid cancer	6.95e-06	0.000125	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PPARG—thyroid cancer	6.89e-06	0.000124	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PTEN—thyroid cancer	6.86e-06	0.000124	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—AKT1—thyroid cancer	6.81e-06	0.000123	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PTEN—thyroid cancer	6.7e-06	0.000121	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PTGS2—thyroid cancer	6.66e-06	0.00012	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—AKT1—thyroid cancer	6.35e-06	0.000115	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PTGS2—thyroid cancer	5.94e-06	0.000107	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—AKT1—thyroid cancer	5.82e-06	0.000105	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PTEN—thyroid cancer	5.81e-06	0.000105	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PTGS2—thyroid cancer	5.8e-06	0.000105	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PTGS2—thyroid cancer	5.47e-06	9.85e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PTGS2—thyroid cancer	5.42e-06	9.77e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—AKT1—thyroid cancer	5.34e-06	9.63e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PTEN—thyroid cancer	5.18e-06	9.34e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PTEN—thyroid cancer	5.06e-06	9.12e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PTEN—thyroid cancer	4.77e-06	8.59e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PTEN—thyroid cancer	4.73e-06	8.52e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PPARG—thyroid cancer	4.54e-06	8.19e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—AKT1—thyroid cancer	3.95e-06	7.12e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—AKT1—thyroid cancer	3.86e-06	6.96e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PTGS2—thyroid cancer	3.57e-06	6.44e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—AKT1—thyroid cancer	3.35e-06	6.03e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PTEN—thyroid cancer	3.12e-06	5.62e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—AKT1—thyroid cancer	2.99e-06	5.38e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—AKT1—thyroid cancer	2.92e-06	5.25e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—AKT1—thyroid cancer	2.75e-06	4.95e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—AKT1—thyroid cancer	2.72e-06	4.91e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—AKT1—thyroid cancer	1.8e-06	3.24e-05	CbGpPWpGaD
